Law360
Sunshine Overseas: Transparency Rules For Life Sciences
November 2012
In the wake of the U.S. Physician Payments Sunshine Act (signed into law in March 2010), European, Asian and Australian governmental bodies and trade associations have been rapidly adopting “Sunshine-like” transparency and disclosure requirements applicable to life sciences companies.
Contacts
Capabilities
Suggested News & Insights
Sidley Secures Plan Confirmation in Prospect Medical Holdings' US$2.3 Billion Chapter 11 CaseDecember 17, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 11, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025Sidley Represents Lumexa Imaging in US$462.5 Million Initial Public OfferingDecember 10, 2025First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical LabsDecember 8, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory